A New Potential Strategy for Treatment of Ischemic Stroke: Targeting TRPM2-NMDAR Association

Neurosci Bull. 2023 Apr;39(4):703-706. doi: 10.1007/s12264-022-00971-1. Epub 2022 Nov 7.

Authors

Jiayun Xu¹, Wei Zhang¹, Jianhong Dong¹, Liying Cao^{2

3}, Zhihui Huang⁴

Affiliations

¹ School of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, China.
² School of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, China. liyingcao@hznu.edu.cn.
³ Laboratory of Aging and Cancer Biology of Zhejiang Province, School of Medicine, Hangzhou Normal University, Hangzhou, 311121, China. liyingcao@hznu.edu.cn.
⁴ School of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, China. huang0069@hznu.edu.cn.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Brain Ischemia* / therapy
Humans
Ischemic Stroke*
Receptors, N-Methyl-D-Aspartate
TRPM Cation Channels*

Substances

Receptors, N-Methyl-D-Aspartate
TRPM Cation Channels
TRPM2 protein, human